Baxter International Inc. (BAX) vs Madrigal Pharmaceuticals, Inc. (MDGL)

A side-by-side comparison of Baxter International Inc. and Madrigal Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BAX vs MDGL

growth of $100 · dividends reinvested · last 10y
BAX -39.8% (-4.9%/yr)MDGL +2930.2% (+40.7%/yr)MDGL compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$60$3,030
BAX MDGL

BAX vs MDGL: by the numbers

  • •BAX is the larger company ($12.48B vs $11.46B market cap).
  • •Both run net losses; BAX's is the smaller (-9.27% vs -25.32% net margin).
  • •BAX pays a dividend (0.17% yield), while MDGL has no payments in the available dividend history.

Metrics side by side

Valuation

MetricBAXMDGL
Forward P/E11.76N/A
P/S ratio1.098.92
P/B ratio2.0121.87
EV / EBITDA29.45N/A
FCF yield5.43%N/A

Profitability

MetricBAXMDGL
Gross margin30.08%91.48%
Operating margin-2.39%-25.13%
Net margin-9.27%-25.32%
ROE-17.13%-62.07%
ROIC-1.61%-37.02%

Dividends

MetricBAXMDGL
Dividend yield0.17%N/A

Growth (annualized)

MetricBAXMDGL
Revenue CAGR (5Y)-1.22%N/A
FCF CAGR (5Y)-12.92%N/A
Total return CAGR (5Y)-19.87%44.41%

Frequently asked

Does BAX or MDGL pay a bigger dividend?
BAX pays a dividend (0.17% yield), while MDGL has no payments in the available dividend history.
How have BAX and MDGL total returns compared?
Over the past 10 years, BAX delivered -5.15% and MDGL delivered 41.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.